ID   S28A3_HUMAN             Reviewed;         691 AA.
AC   Q9HAS3; A8K9Y4; B1AML0; B2RA51; B4E2S8; F5GYE3;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   15-MAR-2017, entry version 132.
DE   RecName: Full=Solute carrier family 28 member 3;
DE   AltName: Full=Concentrative Na(+)-nucleoside cotransporter 3;
DE            Short=CNT 3;
DE            Short=hCNT3;
GN   Name=SLC28A3; Synonyms=CNT3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INDUCTION, TISSUE SPECIFICITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND FUNCTION.
RX   PubMed=11032837; DOI=10.1074/jbc.M007746200;
RA   Ritzel M.W.L., Ng A.M.L., Yao S.Y.M., Graham K., Loewen S.K.,
RA   Smith K.M., Ritzel R.G., Mowles D.A., Carpenter P., Chen X.-Z.,
RA   Karpinski E., Hyde R.J., Baldwin S.A., Cass C.E., Young J.D.;
RT   "Molecular identification and characterization of novel human and
RT   mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and
RT   mCNT3) broadly selective for purine and pyrimidine nucleosides (system
RT   cib).";
RL   J. Biol. Chem. 276:2914-2927(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND
RP   VARIANTS CYS-113; THR-366 AND PHE-513.
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND VARIANTS ASN-5; PHE-131 AND
RP   PHE-513.
RX   PubMed=15861042; DOI=10.1097/01213011-200503000-00006;
RA   Damaraju S., Zhang J., Visser F., Tackaberry T., Dufour J.,
RA   Smith K.M., Slugoski M., Ritzel M.W.L., Baldwin S.A., Young J.D.,
RA   Cass C.E.;
RT   "Identification and functional characterization of variants in human
RT   concentrative nucleoside transporter 3, hCNT3 (SLC28A3), arising from
RT   single nucleotide polymorphisms in coding regions of the hCNT3 gene.";
RL   Pharmacogenet. Genomics 15:173-182(2005).
RN   [7]
RP   FUNCTION.
RX   PubMed=16446384; DOI=10.1124/mol.105.018945;
RA   Hu H., Endres C.J., Chang C., Umapathy N.S., Lee E.-W., Fei Y.-J.,
RA   Itagaki S., Swaan P.W., Ganapathy V., Unadkat J.D.;
RT   "Electrophysiological characterization and modeling of the structure
RT   activity relationship of the human concentrative nucleoside
RT   transporter 3 (hCNT3).";
RL   Mol. Pharmacol. 69:1542-1553(2006).
RN   [8]
RP   FUNCTION.
RX   PubMed=17140564; DOI=10.1016/j.ejphar.2006.10.062;
RA   Yamamoto T., Kuniki K., Takekuma Y., Hirano T., Iseki K., Sugawara M.;
RT   "Ribavirin uptake by cultured human choriocarcinoma (BeWo) cells and
RT   Xenopus laevis oocytes expressing recombinant plasma membrane human
RT   nucleoside transporters.";
RL   Eur. J. Pharmacol. 557:1-8(2007).
RN   [9]
RP   SUBCELLULAR LOCATION, AND ALTERNATIVE SPLICING.
RX   PubMed=18827020; DOI=10.1096/fj.08-113902;
RA   Errasti-Murugarren E., Molina-Arcas M., Casado F.J.,
RA   Pastor-Anglada M.;
RT   "A splice variant of the SLC28A3 gene encodes a novel human
RT   concentrative nucleoside transporter-3 (hCNT3) protein localized in
RT   the endoplasmic reticulum.";
RL   FASEB J. 23:172-182(2009).
RN   [10]
RP   VARIANTS LYS-4; ASN-5; HIS-62; LYS-67; CYS-113; VAL-328; GLN-349;
RP   ARG-367; ILE-418 AND HIS-585, AND CHARACTERIZATION OF VARIANT ARG-367.
RX   PubMed=15738947; DOI=10.1038/sj.tpj.6500303;
RA   Badagnani I., Chan W., Castro R.A., Brett C.M., Huang C.C., Stryke D.,
RA   Kawamoto M., Johns S.J., Ferrin T.E., Carlson E.J., Burchard E.G.,
RA   Giacomini K.M.;
RT   "Functional analysis of genetic variants in the human concentrative
RT   nucleoside transporter 3 (CNT3; SLC28A3).";
RL   Pharmacogenomics J. 5:157-165(2005).
RN   [11]
RP   VARIANT ARG-602, AND CHARACTERIZATION OF VARIANT ARG-602.
RX   PubMed=17993510; DOI=10.1124/mol.107.041848;
RA   Errasti-Murugarren E., Cano-Soldado P., Pastor-Anglada M.,
RA   Casado F.J.;
RT   "Functional characterization of a nucleoside-derived drug transporter
RT   variant (hCNT3C602R) showing altered sodium-binding capacity.";
RL   Mol. Pharmacol. 73:379-386(2008).
CC   -!- FUNCTION: Sodium-dependent, pyrimidine- and purine-selective.
CC       Involved in the homeostasis of endogenous nucleosides. Exhibits
CC       the transport characteristics of the nucleoside transport system
CC       cib or N3 subtype (N3/cib) (with marked transport of both
CC       thymidine and inosine). Employs a 2:1 sodium/nucleoside ratio.
CC       Also able to transport gemcitabine, 3'-azido-3'-deoxythymidine
CC       (AZT), ribavirin and 3-deazauridine. {ECO:0000269|PubMed:11032837,
CC       ECO:0000269|PubMed:16446384, ECO:0000269|PubMed:17140564}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=21.6 uM for uridine {ECO:0000269|PubMed:11032837,
CC         ECO:0000269|PubMed:15861042};
CC         KM=15.4 uM for cytidine {ECO:0000269|PubMed:11032837,
CC         ECO:0000269|PubMed:15861042};
CC         KM=21.2 uM for thymidine {ECO:0000269|PubMed:11032837,
CC         ECO:0000269|PubMed:15861042};
CC         KM=15.1 uM for adenosine {ECO:0000269|PubMed:11032837,
CC         ECO:0000269|PubMed:15861042};
CC         KM=43 uM for guanosine {ECO:0000269|PubMed:11032837,
CC         ECO:0000269|PubMed:15861042};
CC         KM=52.5 uM for inosine {ECO:0000269|PubMed:11032837,
CC         ECO:0000269|PubMed:15861042};
CC         Vmax=25.8 pmol/min/mg enzyme for uridine uptake
CC         {ECO:0000269|PubMed:11032837, ECO:0000269|PubMed:15861042};
CC         Vmax=32.8 pmol/min/mg enzyme for cytidine uptake
CC         {ECO:0000269|PubMed:11032837, ECO:0000269|PubMed:15861042};
CC         Vmax=24.2 pmol/min/mg enzyme for thymidine uptake
CC         {ECO:0000269|PubMed:11032837, ECO:0000269|PubMed:15861042};
CC         Vmax=30.4 pmol/min/mg enzyme for adenosine uptake
CC         {ECO:0000269|PubMed:11032837, ECO:0000269|PubMed:15861042};
CC         Vmax=51.4 pmol/min/mg enzyme for guanosine uptake
CC         {ECO:0000269|PubMed:11032837, ECO:0000269|PubMed:15861042};
CC         Vmax=44.8 pmol/min/mg enzyme for inosine uptake
CC         {ECO:0000269|PubMed:11032837, ECO:0000269|PubMed:15861042};
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cell membrane; Multi-pass
CC       membrane protein.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Endoplasmic reticulum membrane;
CC       Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9HAS3-1; Sequence=Displayed;
CC       Name=2; Synonyms=hCNT3ins;
CC         IsoId=Q9HAS3-2; Sequence=VSP_053848;
CC         Note=Exhibits a shorter half-life than isoform 1, degraded via a
CC         proteasome-dependent pathway.;
CC   -!- TISSUE SPECIFICITY: Expressed in pancreas, bone marrow, trachea,
CC       mammary gland, liver, prostate, and regions of intestine, brain,
CC       lung, placenta, testis, kidney, and heart.
CC       {ECO:0000269|PubMed:11032837}.
CC   -!- INDUCTION: Up-regulated by phorbol myristate acetate (PMA) in HL-
CC       60 cells. {ECO:0000269|PubMed:11032837}.
CC   -!- SIMILARITY: Belongs to the concentrative nucleoside transporter
CC       (CNT) (TC 2.A.41) family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF305210; AAG22551.1; -; mRNA.
DR   EMBL; AK292849; BAF85538.1; -; mRNA.
DR   EMBL; AK304406; BAG65240.1; -; mRNA.
DR   EMBL; AK314039; BAG36748.1; -; mRNA.
DR   EMBL; AL356134; CAH73162.1; -; Genomic_DNA.
DR   EMBL; AL353787; CAH73162.1; JOINED; Genomic_DNA.
DR   EMBL; AL353787; CAI16332.1; -; Genomic_DNA.
DR   EMBL; AL356134; CAI16332.1; JOINED; Genomic_DNA.
DR   EMBL; BC093821; AAH93821.1; -; mRNA.
DR   EMBL; BC093823; AAH93823.1; -; mRNA.
DR   EMBL; CH471089; EAW62686.1; -; Genomic_DNA.
DR   CCDS; CCDS6670.1; -. [Q9HAS3-1]
DR   RefSeq; NP_001186562.1; NM_001199633.1. [Q9HAS3-1]
DR   RefSeq; NP_071410.1; NM_022127.2. [Q9HAS3-1]
DR   UniGene; Hs.535966; -.
DR   ProteinModelPortal; Q9HAS3; -.
DR   SMR; Q9HAS3; -.
DR   STRING; 9606.ENSP00000365413; -.
DR   BindingDB; Q9HAS3; -.
DR   ChEMBL; CHEMBL5707; -.
DR   DrugBank; DB00640; Adenosine.
DR   DrugBank; DB00242; Cladribine.
DR   DrugBank; DB04485; Deoxythymidine.
DR   DrugBank; DB01073; Fludarabine.
DR   DrugBank; DB00441; Gemcitabine.
DR   DrugBank; DB04335; Inosine.
DR   DrugBank; DB01033; Mercaptopurine.
DR   DrugBank; DB00811; Ribavirin.
DR   GuidetoPHARMACOLOGY; 1116; -.
DR   TCDB; 2.A.41.2.8; the concentrative nucleoside transporter (cnt) family.
DR   iPTMnet; Q9HAS3; -.
DR   PhosphoSitePlus; Q9HAS3; -.
DR   BioMuta; SLC28A3; -.
DR   DMDM; 74752767; -.
DR   EPD; Q9HAS3; -.
DR   PaxDb; Q9HAS3; -.
DR   PeptideAtlas; Q9HAS3; -.
DR   PRIDE; Q9HAS3; -.
DR   Ensembl; ENST00000376238; ENSP00000365413; ENSG00000197506. [Q9HAS3-1]
DR   GeneID; 64078; -.
DR   KEGG; hsa:64078; -.
DR   UCSC; uc010mpz.4; human. [Q9HAS3-1]
DR   CTD; 64078; -.
DR   DisGeNET; 64078; -.
DR   GeneCards; SLC28A3; -.
DR   HGNC; HGNC:16484; SLC28A3.
DR   HPA; HPA023311; -.
DR   HPA; HPA024729; -.
DR   MIM; 608269; gene.
DR   neXtProt; NX_Q9HAS3; -.
DR   OpenTargets; ENSG00000197506; -.
DR   PharmGKB; PA426; -.
DR   eggNOG; KOG3747; Eukaryota.
DR   eggNOG; COG1972; LUCA.
DR   GeneTree; ENSGT00390000016025; -.
DR   HOGENOM; HOG000267658; -.
DR   HOVERGEN; HBG054073; -.
DR   InParanoid; Q9HAS3; -.
DR   KO; K11536; -.
DR   OMA; GCCTLLN; -.
DR   OrthoDB; EOG091G05D5; -.
DR   PhylomeDB; Q9HAS3; -.
DR   TreeFam; TF314131; -.
DR   Reactome; R-HSA-83936; Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane.
DR   ChiTaRS; SLC28A3; human.
DR   GenomeRNAi; 64078; -.
DR   PRO; PR:Q9HAS3; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000197506; -.
DR   CleanEx; HS_SLC28A3; -.
DR   Genevisible; Q9HAS3; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005415; F:nucleoside:sodium symporter activity; TAS:Reactome.
DR   GO; GO:0015390; F:purine-specific nucleoside:sodium symporter activity; IBA:GO_Central.
DR   GO; GO:0015389; F:pyrimidine- and adenine-specific:sodium symporter activity; IBA:GO_Central.
DR   GO; GO:0015864; P:pyrimidine nucleoside transport; IBA:GO_Central.
DR   InterPro; IPR008276; C_nuclsd_transpt.
DR   InterPro; IPR018270; C_nuclsd_transpt_met_bac.
DR   InterPro; IPR030211; CNT3.
DR   InterPro; IPR011657; CNT_C_dom.
DR   InterPro; IPR002668; CNT_N_dom.
DR   InterPro; IPR011642; Gate_dom.
DR   PANTHER; PTHR10590; PTHR10590; 1.
DR   PANTHER; PTHR10590:SF26; PTHR10590:SF26; 1.
DR   Pfam; PF07670; Gate; 1.
DR   Pfam; PF07662; Nucleos_tra2_C; 1.
DR   Pfam; PF01773; Nucleos_tra2_N; 1.
DR   TIGRFAMs; TIGR00804; nupC; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Endoplasmic reticulum; Membrane; Polymorphism; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    691       Solute carrier family 28 member 3.
FT                                /FTId=PRO_0000324146.
FT   TOPO_DOM      1    102       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    103    123       Helical. {ECO:0000255}.
FT   TOPO_DOM    124    127       Extracellular. {ECO:0000255}.
FT   TRANSMEM    128    148       Helical. {ECO:0000255}.
FT   TOPO_DOM    149    170       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    171    191       Helical. {ECO:0000255}.
FT   TOPO_DOM    192    200       Extracellular. {ECO:0000255}.
FT   TRANSMEM    201    221       Helical. {ECO:0000255}.
FT   TOPO_DOM    222    223       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    224    244       Helical. {ECO:0000255}.
FT   TOPO_DOM    245    287       Extracellular. {ECO:0000255}.
FT   TRANSMEM    288    308       Helical. {ECO:0000255}.
FT   TOPO_DOM    309    314       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    315    335       Helical. {ECO:0000255}.
FT   TOPO_DOM    336    361       Extracellular. {ECO:0000255}.
FT   TRANSMEM    362    382       Helical. {ECO:0000255}.
FT   TOPO_DOM    383    388       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    389    409       Helical. {ECO:0000255}.
FT   TOPO_DOM    410    443       Extracellular. {ECO:0000255}.
FT   TRANSMEM    444    464       Helical. {ECO:0000255}.
FT   TOPO_DOM    465    479       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    480    500       Helical. {ECO:0000255}.
FT   TOPO_DOM    501    553       Extracellular. {ECO:0000255}.
FT   TRANSMEM    554    574       Helical. {ECO:0000255}.
FT   TOPO_DOM    575    593       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    594    614       Helical. {ECO:0000255}.
FT   TOPO_DOM    615    691       Extracellular. {ECO:0000255}.
FT   VAR_SEQ       1     69       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_053848.
FT   VARIANT       4      4       R -> K (in dbSNP:rs11568401).
FT                                {ECO:0000269|PubMed:15738947}.
FT                                /FTId=VAR_039665.
FT   VARIANT       5      5       S -> N (in dbSNP:rs11568403).
FT                                {ECO:0000269|PubMed:15738947,
FT                                ECO:0000269|PubMed:15861042}.
FT                                /FTId=VAR_039666.
FT   VARIANT      62     62       D -> H (in dbSNP:rs45621433).
FT                                {ECO:0000269|PubMed:15738947}.
FT                                /FTId=VAR_039667.
FT   VARIANT      67     67       R -> K (in dbSNP:rs11568411).
FT                                {ECO:0000269|PubMed:15738947}.
FT                                /FTId=VAR_039668.
FT   VARIANT     113    113       Y -> C (in dbSNP:rs10868138).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15738947}.
FT                                /FTId=VAR_039669.
FT   VARIANT     131    131       L -> F. {ECO:0000269|PubMed:15861042}.
FT                                /FTId=VAR_039670.
FT   VARIANT     221    221       P -> Q (in dbSNP:rs11140503).
FT                                /FTId=VAR_039671.
FT   VARIANT     328    328       I -> V (in dbSNP:rs11568418).
FT                                {ECO:0000269|PubMed:15738947}.
FT                                /FTId=VAR_039672.
FT   VARIANT     349    349       R -> Q (in dbSNP:rs45525131).
FT                                {ECO:0000269|PubMed:15738947}.
FT                                /FTId=VAR_039673.
FT   VARIANT     366    366       A -> T (in dbSNP:rs140138960).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_070606.
FT   VARIANT     367    367       G -> R (reduced transport of inosine and
FT                                thymidine; dbSNP:rs11568388).
FT                                {ECO:0000269|PubMed:15738947}.
FT                                /FTId=VAR_039674.
FT   VARIANT     418    418       L -> I (in dbSNP:rs11568405).
FT                                {ECO:0000269|PubMed:15738947}.
FT                                /FTId=VAR_039675.
FT   VARIANT     513    513       Y -> F (in dbSNP:rs56350726).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15861042}.
FT                                /FTId=VAR_039676.
FT   VARIANT     585    585       R -> H (in dbSNP:rs11568398).
FT                                {ECO:0000269|PubMed:15738947}.
FT                                /FTId=VAR_039677.
FT   VARIANT     602    602       C -> R (lower concentrative capacity and
FT                                altered sodium binding capacity).
FT                                {ECO:0000269|PubMed:17993510}.
FT                                /FTId=VAR_039678.
FT   CONFLICT    251    251       I -> V (in Ref. 2; BAG36748).
FT                                {ECO:0000305}.
FT   CONFLICT    293    293       V -> I (in Ref. 2; BAG36748).
FT                                {ECO:0000305}.
FT   CONFLICT    505    505       F -> L (in Ref. 2; BAG65240).
FT                                {ECO:0000305}.
FT   CONFLICT    628    628       A -> S (in Ref. 2; BAF85538).
FT                                {ECO:0000305}.
FT   CONFLICT    639    639       K -> E (in Ref. 2; BAG36748).
FT                                {ECO:0000305}.
SQ   SEQUENCE   691 AA;  76930 MW;  80FD14518A8BFA61 CRC64;
     MELRSTAAPR AEGYSNVGFQ NEENFLENEN TSGNNSIRSR AVQSREHTNT KQDEEQVTVE
     QDSPRNREHM EDDDEEMQQK GCLERRYDTV CGFCRKHKTT LRHIIWGILL AGYLVMVISA
     CVLNFHRALP LFVITVAAIF FVVWDHLMAK YEHRIDEMLS PGRRLLNSHW FWLKWVIWSS
     LVLAVIFWLA FDTAKLGQQQ LVSFGGLIMY IVLLFLFSKY PTRVYWRPVL WGIGLQFLLG
     LLILRTDPGF IAFDWLGRQV QTFLEYTDAG ASFVFGEKYK DHFFAFKVLP IVVFFSTVMS
     MLYYLGLMQW IIRKVGWIML VTTGSSPIES VVASGNIFVG QTESPLLVRP YLPYITKSEL
     HAIMTAGFST IAGSVLGAYI SFGVPSSHLL TASVMSAPAS LAAAKLFWPE TEKPKITLKN
     AMKMESGDSG NLLEAATQGA SSSISLVANI AVNLIAFLAL LSFMNSALSW FGNMFDYPQL
     SFELICSYIF MPFSFMMGVE WQDSFMVARL IGYKTFFNEF VAYEHLSKWI HLRKEGGPKF
     VNGVQQYISI RSEIIATYAL CGFANIGSLG IVIGGLTSMA PSRKRDIASG AVRALIAGTV
     ACFMTACIAG ILSSTPVDIN CHHVLENAFN STFPGNTTKV IACCQSLLSS TVAKGPGEVI
     PGGNHSLYSL KGCCTLLNPS TFNCNGISNT F
//
